[1] Levey AS, Andreoli SP, Dubose T, et al. Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007[J]. Am J Nephrol, 2007, 22(3): 321-325.
[2] Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: across-sectional survey [J]. Lancet, 2012, 379(9818): 815-822.
[3] National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. [J]. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-266.
[4] 华琦. 解读中国高血压防治指南 (2005年修订版) (一) 高血压诊疗新进展[J]. 中国心血管病研究杂志, 2006, 4(2): 85-88.
[5] Program N C E. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report[J]. Circulation, 2002, 106(25): 3121-3443.
[6] American Diabetes Association. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care, 2008, 31(suppl1): S55-60.
[7] 李瑛, 周乐天, 刘伏友, 等. 湖南省长沙县慢性肾脏病的流行病学研究[J]. 中华肾脏病杂志, 2010, 26(1): 9-14.
[8] 甘参, 李燕, 王湘川, 等. 长沙市孕前优生健康检查人群慢性肾脏病流行病学调查[J]. 湖南师范大学学报 (医学版), 2017, 14(1): 186-189.
[9] Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 5(9): 604-606.
[10] 张路霞, 王海燕. 中国慢性肾脏病的高患病率及其对检验医学的挑战[J]. 中华检验医学杂志, 2012, 35(9): 769-772.
[11] Yoshida T, Takei T, Shirota S, et al. Risk factors for progression in patients with early stage chronic kidney disease in the Japanese population[J]. Intern Med, 2008, 47(21): 1859-1864.
[12] Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey[J]. BMJ, 2006, 333(7577): 1047-1052.
[13] 殷黎, 李光春, 刘慧琳. 湖南省成年人群主要慢性病患病及知晓、治疗和控制情况分析[J]. 现代预防医学, 2014, 41(24): 4465-4468.
基金
湖南省卫生计生委基金项目(NO.B2016150);湖南省残联康复科研项目(NO.2017xk010)